|Former Common name||C.Dravet, BALB-Scn1a|
|H-2 Haplotype||No Data|
|Strain development||Developed by Yoshibumi Matsushima, Saitama Cancer Center, Research Institute for Clinical Oncology.|
|Strain description||Scn1a spontaneous mutant (Dravet syndrome) mice arose in BALB/c. Heterozygous mice show heat-induced epileptic seizure. Homozygous mutant mice show severe myoclonic epilepsy in infancy, and die at around 3 weeks old. Under investigation. BALB/cCrSlc background (semicongenic) (RBRC06422).|
|Colony maintenance||Heterozygote x Heterozygote [or Crossing to BALB/cCrSlc]|
|Symbol name||sodium channel, voltage-gated, type I, alpha|
|Common name||No Data|
|Symbol description||No Data|
|Research applications||Mouse Models for Human Disease,
|Specific Term and Conditions||The following terms and conditions will be requested by the DEPOSITOR.
In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested.
後日指定。(will be announced.)
For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR.
|Depositor||Matsushima, Yoshibumi (Saitama Cancer Center)|
|Strain Status /